In 5 patients (2 treated with ipilimumab and 3 with pembrolizumab), metastatic lesions could be visualized with a positive correlation between size of the tumor lesion and [99mTc]Tc-HYNIC-IL2 accumulation, both before and after 12 weeks of therapy. The gene discussed is IL2; the disease is neoplasm.